Paclitaxel plus hydroxyurea as second line therapy for non-small cell lung cancer

This publication has 11 references indexed in Scilit:

• Active vs. passive resistance, dose-response relationships, high dose chemotherapy, and resistance modulation: a hypothesis
  Investigational New Drugs, 1996
• Parallel assessment of glutathione-based detoxifying enzymes, O6-alkylguanine-dna alkyltransferase and P-glycoprotein as indicators of drug resistance in tumor and normal lung of patients with lung cancer
  International Journal of Cancer, 1994
• Expression of the Multidrug Resistance Gene (MDR1) in Non‐small Cell Lung Cancer
  Japanese Journal of Cancer Research, 1994
• Immunohistochemical study of P-glycoprotein distribution in lung cancer
  Lung Cancer, 1993
• Phase II Study of Taxol, Merbarone, and Piroxantrone in Stage IV Non-Small-Cell Lung Cancer: The Eastern Cooperative Oncology Group Results
  JNCI Journal of the National Cancer Institute, 1993
• Relationship of inherent resistance to doxorubicin, proliferative activity and expression of P-glycoprotein 170, and glutathione S-transf erase-π in human lung tumors
  Cancer, 1992
• Double minutes arise from circular extrachromosomal DNA intermediates which integrate into chromosomal sites in human HL-60 leukemia cells.
  Journal of Clinical Investigation, 1990
• DOUBLE MINUTES AND HOMOGENEOUSLY STAINING REGIONS: Gene Amplification in Mammalian Cells
  Annual Review of Genetics, 1982
• Double minutes in human tumor cells
  Cancer Genetics and Cytogenetics, 1982
• Hydroxyurea
  Published by Springer Nature ,1970